Latest updates

New or recently updated pages

1 Diabetes mellitus and cancer of the pancreas
2 Diabetes and pancreatic cancer
3 Faecal microbiota transplantation (FMT) in ulcerative colitis (UC)
4 Mineralocorticoid receptor antagonists (MRAs) evidence in heart failure with preserved ejection fraction (HFpEF) Cochrane review 2021
5 Angiotensin receptor neprilysin inhibitors (ARNI) evidence in heart failure with preserved ejection fraction (HFpEF) Cochrane review 2021
6 Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction (HFpEF)
7 Statin treatment and miconazole gel
8 Miconazole oral gel to treat oral thrush in adults taking statins
9 NICE guidance - mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders
10 Approximate relative potencies of opioids (opiates) in chronic usage in comparison to morphine

Trending topics

Most popular pages in the past week

1 General practice
2 Systemic hypertension
3 HRT
4 Hypertension
5 PCOS
6 Gout
7 Migraine
8 Hyponatraemia
9 Acne vulgaris
10 Croup

Introducing

GPn Pro logo
  • Checkmark icon Track your pages, video views and more
  • Checkmark icon Accumulate CPD credits while you work
  • Checkmark icon Add reflective notes
  • Checkmark icon Export your yearly CPD statement
  • Checkmark icon Access premium content
Upgrade now

From the Editor-in-Chief

Welcome to GPnotebook – a concise synopsis of clinical medicine focused on the needs of the general practitioner, which aims to help you make fast, evidence-based decisions.

We’re pleased to announce the launch of GPnotebook Pro – a subscription service that makes it quick and easy for you to build your yearly CPD portfolio through your activity with GPnotebook during consultations and at other times. In addition, GPnotebook Pro users have access to a growing library of exclusive content.

To support the launch of GPnotebook Pro, we have collaborated with InterACT Medical Education, a CPD-accredited non-promotional medical education resource provided by AstraZeneca. The support provided by AstraZeneca will enable UK healthcare professionals to register to access GPnotebook Pro without charge for a period of 6 months. AstraZeneca has no editorial input into or control over the content of GPnotebook. Click here to find out how to start your 6-month introductory free access period.

We hope you find GPnotebook Pro helpful, and as always, if you have any comments or criticisms, please do not hesitate to contact us.

Best,
Dr Jim McMorran
Dr Jim McMorran
Co-founder and Editor-in-Chief, GPnotebook

GPnTV logo

Quick video updates on the clinical developments that matter most

Watch now
GPn Podcast logo

A bite-sized, regular chat for all healthcare professionals working in primary care

Listen now